Xtant Medical Holdings (XTNT) is scheduled to report Q3 earnings on November 9, 2026. Analysts estimate EPS of $-0.01 and quarterly revenue of $27.09M.
In the most recent quarter (Q2), Xtant Medical Holdings reported EPS of $-0.03, missing estimates of $-0.02 by 0.5%. Revenue came in at $23.03M, missing the estimate of $24.88M by 0.07%.
Over the last 4 quarters, Xtant Medical Holdings has averaged an EPS surprise of 0.75% and a revenue surprise of 0.05%.
Earnings Date
Nov 9
EPS Estimate
$-0.010
Quarterly Revenue Estimate
$27.09M
Annual Revenue
$109.53M
as of Jun 30
Analyze the earnings history of Xtant Medical Holdings using advanced sorting and filters.
The chart below shows Xtant Medical Holdings's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Xtant Medical Holdings's reported revenue compared to analyst estimates over recent quarters.
Xtant Medical Holdings (XTNT) is scheduled to report earnings on November 9, 2026. The last reported earnings were for reported on August 11, 2026 for Q2.
The Actual EPS was $-0.03, which missed the estimate of $-0.02.
The Actual Revenue was $23.03M, which missed the estimate of $24.88M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.03 | $-0.02 | -50.0 % |
| Q1 | May 13, 2026 | $-0.02 | $-0.02 | 0.00 % |
| Q4 | Mar 31, 2026 | $0 | $-0.01 | 100.0 % |
| Q3 | Nov 10, 2025 | $0.01 | $-0.02 | 150.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $23.03M | $24.88M | -7.41 % |
| Q1 | May 13, 2026 | $20.88M | $19.79M | 5.55 % |
| Q4 | Mar 31, 2026 | $32.36M | $30.75M | 5.23 % |
| Q3 | Nov 10, 2025 | $33.30M | $32.70M | 1.85 % |